Ardagh Glass Packaging to make debut exhibition at CPHI Barcelona 2023

Ardagh Glass Packing (AGP)-Europe will be exhibiting for the first time at this year’s CPHI from 24 to 26 October, in Barcelona.

The AGP team will be on hand to welcome people to the stand, to discuss the requirements of the sector and showcase the range of pharmaceutical glass containers available.

Ingo Erdmann, Senior Sales Manager Pharma & Chemical, Ardagh Glass Packaging–Germany commented “We have been supplying the pharmaceutical sector for over 50 years with premium quality glass packaging, which perfectly meets the complex requirements of these vital industries. CPHI is the biggest pharma event of the year, and we are excited to exhibit here for the first time among pharmaceutical professionals and innovators.”

AGP can be found in Hall 2, stand 2A22.  

www.ardaghgroup.com

 

04.10.2023, Ardagh Glass Packaging

News material on the Site is copyright and belongs to the Company or to its third party news provider, and all rights are reserved. Any User who accesses such material may do so only for its own personal use, and the use of such material is at the sole risk of the User. Redistribution or other commercial exploitation of such news material is expressly prohibited. Where such news material is provided by a third party, each User agrees to observe and be bound by the specific terms of use applying to such news material. We do not represent or endorse the accuracy or reliability of any of the info contained in any news or external websites referred to in the news.

Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.